Edwards Lifesciences Corp (NYSE:EW)
$ 89.78 0.64 (0.72%) Market Cap: 54.10 Bil Enterprise Value: 52.72 Bil PE Ratio: 38.70 PB Ratio: 7.60 GF Score: 98/100

Edwards Lifesciences Corp at Cowen HealthCare Conference Transcript

Mar 02, 2020 / 06:30PM GMT
Release Date Price: $70.97 (+3.94%)
Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Okay. We're going to get started. I'm Josh Jennings from the medical devices team here at Cowen. Thanks, everyone, in the audience for coming to this session, the first post-lunch fireside chat. And we're pleased to have Edwards Lifesciences here and the Corporate Vice President and Chief Financial Officer, Scott Ullem. Scott, thanks so much for joining us this year again, and looking forward to our discussion.

Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO

Yes. Our pleasure. Certainly, thanks, everyone, for coming.

Questions & Answers

Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Well, clearly, our front-burner issue clearly is COVID-19. And just wanted to maybe review, I mean, China's been the hardest hit, just Edwards' exposure to China to start with. And then maybe we can just ask a couple of more follow-up questions. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot